IndraLab

Statements


SCN8A inhibits MAP3K7. 1 / 1
| 1

reach
"MED suppressed the activation of TAK1 induced by LPS, indicating that MED negatively affects IKK, p38, and JNK pathways through blocking the activation of TAK1."